The Fibromyalgia Treatment Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Fibromyalgia Treatment Drug size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Fibromyalgia Treatment Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Fibromyalgia Treatment Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cymbalta (Duloxetine)
Savella (Milnacipran)
Lyrica (Pregabalin)
Pancuronium
Others
Market segment by Application, can be divided into
Hospital
Clinic
Household
Others
Market segment by players, this report covers
Pfizer
Eli Lilly
Actavis Generics
Merck Sharp and Dohme
Daiichi Sankyo
Innovative Med Concepts
Meda
Meiji Seika
Switch Biotech
Theravance
Zynerba Pharmaceuticals
Tonix Pharmaceuticals Holding Corp. (TNXP)
Daiichi Sankyo
Forest Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
Pierre Fabre Medicament
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Fibromyalgia Treatment Drug
1.2 Classification of Fibromyalgia Treatment Drug by Type
1.2.1 Overview: Global Fibromyalgia Treatment Drug Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Fibromyalgia Treatment Drug Revenue Market Share by Type in 2020
1.2.3 Cymbalta (Duloxetine)
1.2.4 Savella (Milnacipran)
1.2.5 Lyrica (Pregabalin)
1.2.6 Pancuronium
1.2.7 Others
1.3 Global Fibromyalgia Treatment Drug Market by Application
1.3.1 Overview: Global Fibromyalgia Treatment Drug Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Others
1.4 Global Fibromyalgia Treatment Drug Market Size & Forecast
1.5 Global Fibromyalgia Treatment Drug Market Size and Forecast by Region
1.5.1 Global Fibromyalgia Treatment Drug Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Fibromyalgia Treatment Drug Market Size by Region, (2016-2021)
1.5.3 North America Fibromyalgia Treatment Drug Market Size and Prospect (2016-2026)
1.5.4 Europe Fibromyalgia Treatment Drug Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Fibromyalgia Treatment Drug Market Size and Prospect (2016-2026)
1.5.6 South America Fibromyalgia Treatment Drug Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Fibromyalgia Treatment Drug Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Fibromyalgia Treatment Drug Market Drivers
1.6.2 Fibromyalgia Treatment Drug Market Restraints
1.6.3 Fibromyalgia Treatment Drug Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Fibromyalgia Treatment Drug Product and Solutions
2.1.4 Pfizer Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Fibromyalgia Treatment Drug Product and Solutions
2.2.4 Eli Lilly Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Eli Lilly Recent Developments and Future Plans
2.3 Actavis Generics
2.3.1 Actavis Generics Details
2.3.2 Actavis Generics Major Business
2.3.3 Actavis Generics Fibromyalgia Treatment Drug Product and Solutions
2.3.4 Actavis Generics Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Actavis Generics Recent Developments and Future Plans
2.4 Merck Sharp and Dohme
2.4.1 Merck Sharp and Dohme Details
2.4.2 Merck Sharp and Dohme Major Business
2.4.3 Merck Sharp and Dohme Fibromyalgia Treatment Drug Product and Solutions
2.4.4 Merck Sharp and Dohme Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Merck Sharp and Dohme Recent Developments and Future Plans
2.5 Daiichi Sankyo
2.5.1 Daiichi Sankyo Details
2.5.2 Daiichi Sankyo Major Business
2.5.3 Daiichi Sankyo Fibromyalgia Treatment Drug Product and Solutions
2.5.4 Daiichi Sankyo Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Daiichi Sankyo Recent Developments and Future Plans
2.6 Innovative Med Concepts
2.6.1 Innovative Med Concepts Details
2.6.2 Innovative Med Concepts Major Business
2.6.3 Innovative Med Concepts Fibromyalgia Treatment Drug Product and Solutions
2.6.4 Innovative Med Concepts Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Innovative Med Concepts Recent Developments and Future Plans
2.7 Meda
2.7.1 Meda Details
2.7.2 Meda Major Business
2.7.3 Meda Fibromyalgia Treatment Drug Product and Solutions
2.7.4 Meda Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Meda Recent Developments and Future Plans
2.8 Meiji Seika
2.8.1 Meiji Seika Details
2.8.2 Meiji Seika Major Business
2.8.3 Meiji Seika Fibromyalgia Treatment Drug Product and Solutions
2.8.4 Meiji Seika Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Meiji Seika Recent Developments and Future Plans
2.9 Switch Biotech
2.9.1 Switch Biotech Details
2.9.2 Switch Biotech Major Business
2.9.3 Switch Biotech Fibromyalgia Treatment Drug Product and Solutions
2.9.4 Switch Biotech Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Switch Biotech Recent Developments and Future Plans
2.10 Theravance
2.10.1 Theravance Details
2.10.2 Theravance Major Business
2.10.3 Theravance Fibromyalgia Treatment Drug Product and Solutions
2.10.4 Theravance Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Theravance Recent Developments and Future Plans
2.11 Zynerba Pharmaceuticals
2.11.1 Zynerba Pharmaceuticals Details
2.11.2 Zynerba Pharmaceuticals Major Business
2.11.3 Zynerba Pharmaceuticals Fibromyalgia Treatment Drug Product and Solutions
2.11.4 Zynerba Pharmaceuticals Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Zynerba Pharmaceuticals Recent Developments and Future Plans
2.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
2.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Details
2.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Major Business
2.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Treatment Drug Product and Solutions
2.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments and Future Plans
2.13 Daiichi Sankyo
2.13.1 Daiichi Sankyo Details
2.13.2 Daiichi Sankyo Major Business
2.13.3 Daiichi Sankyo Fibromyalgia Treatment Drug Product and Solutions
2.13.4 Daiichi Sankyo Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Daiichi Sankyo Recent Developments and Future Plans
2.14 Forest Pharmaceuticals, Inc.
2.14.1 Forest Pharmaceuticals, Inc. Details
2.14.2 Forest Pharmaceuticals, Inc. Major Business
2.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Treatment Drug Product and Solutions
2.14.4 Forest Pharmaceuticals, Inc. Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Forest Pharmaceuticals, Inc. Recent Developments and Future Plans
2.15 Boehringer Ingelheim GmbH
2.15.1 Boehringer Ingelheim GmbH Details
2.15.2 Boehringer Ingelheim GmbH Major Business
2.15.3 Boehringer Ingelheim GmbH Fibromyalgia Treatment Drug Product and Solutions
2.15.4 Boehringer Ingelheim GmbH Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans
2.16 Pierre Fabre Medicament
2.16.1 Pierre Fabre Medicament Details
2.16.2 Pierre Fabre Medicament Major Business
2.16.3 Pierre Fabre Medicament Fibromyalgia Treatment Drug Product and Solutions
2.16.4 Pierre Fabre Medicament Fibromyalgia Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Pierre Fabre Medicament Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Fibromyalgia Treatment Drug Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Fibromyalgia Treatment Drug Players Market Share
3.2.2 Top 10 Fibromyalgia Treatment Drug Players Market Share
3.2.3 Market Competition Trend
3.3 Fibromyalgia Treatment Drug Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Fibromyalgia Treatment Drug Revenue and Market Share by Type (2016-2021)
4.2 Global Fibromyalgia Treatment Drug Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Fibromyalgia Treatment Drug Revenue Market Share by Application (2016-2021)
5.2 Fibromyalgia Treatment Drug Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Fibromyalgia Treatment Drug Revenue by Type (2016-2026)
6.2 North America Fibromyalgia Treatment Drug Revenue by Application (2016-2026)
6.3 North America Fibromyalgia Treatment Drug Market Size by Country
6.3.1 North America Fibromyalgia Treatment Drug Revenue by Country (2016-2026)
6.3.2 United States Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
6.3.3 Canada Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
6.3.4 Mexico Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Fibromyalgia Treatment Drug Revenue by Type (2016-2026)
7.2 Europe Fibromyalgia Treatment Drug Revenue by Application (2016-2026)
7.3 Europe Fibromyalgia Treatment Drug Market Size by Country
7.3.1 Europe Fibromyalgia Treatment Drug Revenue by Country (2016-2026)
7.3.2 Germany Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
7.3.3 France Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
7.3.5 Russia Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
7.3.6 Italy Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Fibromyalgia Treatment Drug Revenue by Type (2016-2026)
8.2 Asia-Pacific Fibromyalgia Treatment Drug Revenue by Application (2016-2026)
8.3 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region
8.3.1 Asia-Pacific Fibromyalgia Treatment Drug Revenue by Region (2016-2026)
8.3.2 China Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
8.3.3 Japan Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
8.3.4 South Korea Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
8.3.5 India Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
8.3.7 Australia Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Fibromyalgia Treatment Drug Revenue by Type (2016-2026)
9.2 South America Fibromyalgia Treatment Drug Revenue by Application (2016-2026)
9.3 South America Fibromyalgia Treatment Drug Market Size by Country
9.3.1 South America Fibromyalgia Treatment Drug Revenue by Country (2016-2026)
9.3.2 Brazil Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
9.3.3 Argentina Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Fibromyalgia Treatment Drug Revenue by Type (2016-2026)
10.2 Middle East & Africa Fibromyalgia Treatment Drug Revenue by Application (2016-2026)
10.3 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country
10.3.1 Middle East & Africa Fibromyalgia Treatment Drug Revenue by Country (2016-2026)
10.3.2 Turkey Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
10.3.4 UAE Fibromyalgia Treatment Drug Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Fibromyalgia Treatment Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Fibromyalgia Treatment Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Fibromyalgia Treatment Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Fibromyalgia Treatment Drug Revenue (USD Million) by Region (2016-2021)
Table 5. Global Fibromyalgia Treatment Drug Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Fibromyalgia Treatment Drug Product and Solutions
Table 9. Pfizer Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 11. Eli Lilly Major Business
Table 12. Eli Lilly Fibromyalgia Treatment Drug Product and Solutions
Table 13. Eli Lilly Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Actavis Generics Corporate Information, Head Office, and Major Competitors
Table 15. Actavis Generics Major Business
Table 16. Actavis Generics Fibromyalgia Treatment Drug Product and Solutions
Table 17. Actavis Generics Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Merck Sharp and Dohme Corporate Information, Head Office, and Major Competitors
Table 19. Merck Sharp and Dohme Major Business
Table 20. Merck Sharp and Dohme Fibromyalgia Treatment Drug Product and Solutions
Table 21. Merck Sharp and Dohme Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Daiichi Sankyo Corporate Information, Head Office, and Major Competitors
Table 23. Daiichi Sankyo Major Business
Table 24. Daiichi Sankyo Fibromyalgia Treatment Drug Product and Solutions
Table 25. Daiichi Sankyo Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Innovative Med Concepts Corporate Information, Head Office, and Major Competitors
Table 27. Innovative Med Concepts Major Business
Table 28. Innovative Med Concepts Fibromyalgia Treatment Drug Product and Solutions
Table 29. Innovative Med Concepts Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Meda Corporate Information, Head Office, and Major Competitors
Table 31. Meda Major Business
Table 32. Meda Fibromyalgia Treatment Drug Product and Solutions
Table 33. Meda Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Meiji Seika Corporate Information, Head Office, and Major Competitors
Table 35. Meiji Seika Major Business
Table 36. Meiji Seika Fibromyalgia Treatment Drug Product and Solutions
Table 37. Meiji Seika Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Switch Biotech Corporate Information, Head Office, and Major Competitors
Table 39. Switch Biotech Major Business
Table 40. Switch Biotech Fibromyalgia Treatment Drug Product and Solutions
Table 41. Switch Biotech Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Theravance Corporate Information, Head Office, and Major Competitors
Table 43. Theravance Major Business
Table 44. Theravance Fibromyalgia Treatment Drug Product and Solutions
Table 45. Theravance Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Zynerba Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 47. Zynerba Pharmaceuticals Major Business
Table 48. Zynerba Pharmaceuticals Fibromyalgia Treatment Drug Product and Solutions
Table 49. Zynerba Pharmaceuticals Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Tonix Pharmaceuticals Holding Corp. (TNXP) Corporate Information, Head Office, and Major Competitors
Table 51. Tonix Pharmaceuticals Holding Corp. (TNXP) Major Business
Table 52. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Treatment Drug Product and Solutions
Table 53. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Daiichi Sankyo Corporate Information, Head Office, and Major Competitors
Table 55. Daiichi Sankyo Major Business
Table 56. Daiichi Sankyo Fibromyalgia Treatment Drug Product and Solutions
Table 57. Daiichi Sankyo Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Forest Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 59. Forest Pharmaceuticals, Inc. Major Business
Table 60. Forest Pharmaceuticals, Inc. Fibromyalgia Treatment Drug Product and Solutions
Table 61. Forest Pharmaceuticals, Inc. Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Boehringer Ingelheim GmbH Corporate Information, Head Office, and Major Competitors
Table 63. Boehringer Ingelheim GmbH Major Business
Table 64. Boehringer Ingelheim GmbH Fibromyalgia Treatment Drug Product and Solutions
Table 65. Boehringer Ingelheim GmbH Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Pierre Fabre Medicament Corporate Information, Head Office, and Major Competitors
Table 67. Pierre Fabre Medicament Major Business
Table 68. Pierre Fabre Medicament Fibromyalgia Treatment Drug Product and Solutions
Table 69. Pierre Fabre Medicament Fibromyalgia Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Global Fibromyalgia Treatment Drug Revenue (USD Million) by Players (2019-2021)
Table 71. Global Fibromyalgia Treatment Drug Revenue Share by Players (2019-2021)
Table 72. Breakdown of Fibromyalgia Treatment Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Fibromyalgia Treatment Drug Players Head Office, Products and Services Provided
Table 74. Fibromyalgia Treatment Drug Mergers & Acquisitions in the Past Five Years
Table 75. Fibromyalgia Treatment Drug New Entrants and Expansion Plans
Table 76. Global Fibromyalgia Treatment Drug Revenue (USD Million) by Type (2016-2021)
Table 77. Global Fibromyalgia Treatment Drug Revenue Share by Type (2016-2021)
Table 78. Global Fibromyalgia Treatment Drug Revenue Forecast by Type (2021-2026)
Table 79. Global Fibromyalgia Treatment Drug Revenue by Application (2016-2021)
Table 80. Global Fibromyalgia Treatment Drug Revenue Forecast by Application (2021-2026)
Table 81. North America Fibromyalgia Treatment Drug Revenue by Type (2016-2021) & (USD Million)
Table 82. North America Fibromyalgia Treatment Drug Revenue by Type (2021-2026) & (USD Million)
Table 83. North America Fibromyalgia Treatment Drug Revenue by Application (2016-2021) & (USD Million)
Table 84. North America Fibromyalgia Treatment Drug Revenue by Application (2021-2026) & (USD Million)
Table 85. North America Fibromyalgia Treatment Drug Revenue by Country (2016-2021) & (USD Million)
Table 86. North America Fibromyalgia Treatment Drug Revenue by Country (2021-2026) & (USD Million)
Table 87. Europe Fibromyalgia Treatment Drug Revenue by Type (2016-2021) & (USD Million)
Table 88. Europe Fibromyalgia Treatment Drug Revenue by Type (2021-2026) & (USD Million)
Table 89. Europe Fibromyalgia Treatment Drug Revenue by Application (2016-2021) & (USD Million)
Table 90. Europe Fibromyalgia Treatment Drug Revenue by Application (2021-2026) & (USD Million)
Table 91. Europe Fibromyalgia Treatment Drug Revenue by Country (2016-2021) & (USD Million)
Table 92. Europe Fibromyalgia Treatment Drug Revenue by Country (2021-2026) & (USD Million)
Table 93. Asia-Pacific Fibromyalgia Treatment Drug Revenue by Type (2016-2021) & (USD Million)
Table 94. Asia-Pacific Fibromyalgia Treatment Drug Revenue by Type (2021-2026) & (USD Million)
Table 95. Asia-Pacific Fibromyalgia Treatment Drug Revenue by Application (2016-2021) & (USD Million)
Table 96. Asia-Pacific Fibromyalgia Treatment Drug Revenue by Application (2021-2026) & (USD Million)
Table 97. Asia-Pacific Fibromyalgia Treatment Drug Revenue by Region (2016-2021) & (USD Million)
Table 98. Asia-Pacific Fibromyalgia Treatment Drug Revenue by Region (2021-2026) & (USD Million)
Table 99. South America Fibromyalgia Treatment Drug Revenue by Type (2016-2021) & (USD Million)
Table 100. South America Fibromyalgia Treatment Drug Revenue by Type (2021-2026) & (USD Million)
Table 101. South America Fibromyalgia Treatment Drug Revenue by Application (2016-2021) & (USD Million)
Table 102. South America Fibromyalgia Treatment Drug Revenue by Application (2021-2026) & (USD Million)
Table 103. South America Fibromyalgia Treatment Drug Revenue by Country (2016-2021) & (USD Million)
Table 104. South America Fibromyalgia Treatment Drug Revenue by Country (2021-2026) & (USD Million)
Table 105. Middle East & Africa Fibromyalgia Treatment Drug Revenue by Type (2016-2021) & (USD Million)
Table 106. Middle East & Africa Fibromyalgia Treatment Drug Revenue by Type (2021-2026) & (USD Million)
Table 107. Middle East & Africa Fibromyalgia Treatment Drug Revenue by Application (2016-2021) & (USD Million)
Table 108. Middle East & Africa Fibromyalgia Treatment Drug Revenue by Application (2021-2026) & (USD Million)
Table 109. Middle East & Africa Fibromyalgia Treatment Drug Revenue by Country (2016-2021) & (USD Million)
Table 110. Middle East & Africa Fibromyalgia Treatment Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Fibromyalgia Treatment Drug Picture
Figure 2. Global Fibromyalgia Treatment Drug Revenue Market Share by Type in 2020
Figure 3. Cymbalta (Duloxetine)
Figure 4. Savella (Milnacipran)
Figure 5. Lyrica (Pregabalin)
Figure 6. Pancuronium
Figure 7. Others
Figure 8. Fibromyalgia Treatment Drug Revenue Market Share by Application in 2020
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Household Picture
Figure 12. Others Picture
Figure 13. Global Fibromyalgia Treatment Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Fibromyalgia Treatment Drug Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Fibromyalgia Treatment Drug Revenue Market Share by Region (2016-2026)
Figure 16. Global Fibromyalgia Treatment Drug Revenue Market Share by Region in 2020
Figure 17. North America Fibromyalgia Treatment Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Fibromyalgia Treatment Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Fibromyalgia Treatment Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Fibromyalgia Treatment Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Fibromyalgia Treatment Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Fibromyalgia Treatment Drug Market Drivers
Figure 23. Fibromyalgia Treatment Drug Market Restraints
Figure 24. Fibromyalgia Treatment Drug Market Trends
Figure 25. Pfizer Recent Developments and Future Plans
Figure 26. Eli Lilly Recent Developments and Future Plans
Figure 27. Actavis Generics Recent Developments and Future Plans
Figure 28. Merck Sharp and Dohme Recent Developments and Future Plans
Figure 29. Daiichi Sankyo Recent Developments and Future Plans
Figure 30. Innovative Med Concepts Recent Developments and Future Plans
Figure 31. Meda Recent Developments and Future Plans
Figure 32. Meiji Seika Recent Developments and Future Plans
Figure 33. Switch Biotech Recent Developments and Future Plans
Figure 34. Theravance Recent Developments and Future Plans
Figure 35. Zynerba Pharmaceuticals Recent Developments and Future Plans
Figure 36. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments and Future Plans
Figure 37. Daiichi Sankyo Recent Developments and Future Plans
Figure 38. Forest Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 39. Boehringer Ingelheim GmbH Recent Developments and Future Plans
Figure 40. Pierre Fabre Medicament Recent Developments and Future Plans
Figure 41. Global Fibromyalgia Treatment Drug Revenue Share by Players in 2020
Figure 42. Fibromyalgia Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 43. Global Top 3 Players Fibromyalgia Treatment Drug Revenue Market Share in 2020
Figure 44. Global Top 10 Players Fibromyalgia Treatment Drug Revenue Market Share in 2020
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 46. Global Fibromyalgia Treatment Drug Revenue Share by Type in 2020
Figure 47. Global Fibromyalgia Treatment Drug Market Share Forecast by Type (2021-2026)
Figure 48. Global Fibromyalgia Treatment Drug Revenue Share by Application in 2020
Figure 49. Global Fibromyalgia Treatment Drug Market Share Forecast by Application (2021-2026)
Figure 50. North America Fibromyalgia Treatment Drug Sales Market Share by Type (2016-2026)
Figure 51. North America Fibromyalgia Treatment Drug Sales Market Share by Application (2016-2026)
Figure 52. North America Fibromyalgia Treatment Drug Revenue Market Share by Country (2016-2026)
Figure 53. United States Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Canada Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Mexico Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Europe Fibromyalgia Treatment Drug Sales Market Share by Type (2016-2026)
Figure 57. Europe Fibromyalgia Treatment Drug Sales Market Share by Application (2016-2026)
Figure 58. Europe Fibromyalgia Treatment Drug Revenue Market Share by Country (2016-2026)
Figure 59. Germany Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. France Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. United Kingdom Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Russia Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Italy Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Asia-Pacific Fibromyalgia Treatment Drug Sales Market Share by Type (2016-2026)
Figure 65. Asia-Pacific Fibromyalgia Treatment Drug Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Fibromyalgia Treatment Drug Revenue Market Share by Region (2016-2026)
Figure 67. China Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Japan Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South Korea Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. India Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Southeast Asia Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Australia Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. South America Fibromyalgia Treatment Drug Sales Market Share by Type (2016-2026)
Figure 74. South America Fibromyalgia Treatment Drug Sales Market Share by Application (2016-2026)
Figure 75. South America Fibromyalgia Treatment Drug Revenue Market Share by Country (2016-2026)
Figure 76. Brazil Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Argentina Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Middle East and Africa Fibromyalgia Treatment Drug Sales Market Share by Type (2016-2026)
Figure 79. Middle East and Africa Fibromyalgia Treatment Drug Sales Market Share by Application (2016-2026)
Figure 80. Middle East and Africa Fibromyalgia Treatment Drug Revenue Market Share by Country (2016-2026)
Figure 81. Turkey Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. UAE Fibromyalgia Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source